Get our Free Patent Expiration Newsletter

Serving leading biopharmaceutical companies globally:

Colorcon
McKinsey
Baxter
Medtronic
Mallinckrodt
McKesson

Last Updated: December 7, 2019

DrugPatentWatch Database Preview

Litigation Details for Kentucky Laborers District Council Health and Welfare Fund v. AbbVie Inc. (N.D. Ill. 2019)

See Plans and Pricing

« Back to Dashboard

Kentucky Laborers District Council Health and Welfare Fund v. AbbVie Inc. (N.D. Ill. 2019)

Docket   Start Trial Date Filed 2019-04-16
Court District Court, N.D. Illinois Date Terminated
Cause 28:1332 Diversity-Fraud Assigned To John Robert Blakey
Jury Demand Plaintiff Referred To
Parties ABBVIE BIOTECHNOLOGY LTD; ABBVIE BIOTECHNOLOGY LTD.; ABBVIE INC.; AMGEN INC.; KENTUCKY LABORERS DISTRICT COUNCIL HEALTH AND WELFARE FUND
Patents 7,820,799; 8,093,045; 8,663,945; 8,911,964; 8,926,975; 8,961,973; 8,986,693; 9,018,361; 9,067,992; 9,090,689; 9,090,867; 9,096,666; 9,187,559; 9,255,143; 9,266,949; 9,359,434; 9,365,645; 9,512,216
Attorneys Justin Nicholas Boley; Kenneth A. Wexler
Firms Wexler Wallace LLP
Link to Docket External link to docket
Biologic Drugs cited in Kentucky Laborers District Council Health and Welfare Fund v. AbbVie Inc.
The biologic drugs covered by the patents cited in this case are   Start Trial and   Start Trial .

Details for Kentucky Laborers District Council Health and Welfare Fund v. AbbVie Inc. (N.D. Ill. 2019)

Date Filed Document No. Description Snippet Link To Document
2019-04-16 1 Complaint in light of U.S. Patent No. 5,429,746 and a publication of U.S. Patent No. 7,820,799. Although it does… second patent not patentably distinct from claims in a first patent. 67. Patent prosecutions…hundreds of patents. 3. AbbVie built its patent thicket without regard to patent merits… AbbVie’s use patents and found three patents invalid due to obviousness: U.S. Patent No. 8,889,135; …non-inventive patents for the purpose of developing a ‘patent thicket,’ using the patenting process itself External link to document
>Date Filed >Document No. >Description >Snippet >Link To Document

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Boehringer Ingelheim
Moodys
Merck
Harvard Business School
Dow
AstraZeneca

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.